T1	Participants 748 775	Two hundred ninety patients
T2	Participants 1012 1112	460-467 in the placebo group and 750 mg/day group versus 480-551 in the 1,000- and 2,000-mg/day arms
T3	Participants 1292 1319	Over twice as many patients
